Inventor · disambiguated record
Roland Grandel
Also filed as: GRANDEL ROLAND
23 granted patents·4 pending applications·314 citations·filing 1999–2012
94Inventor score
Top patents by PatentIndex Score
27 records- 0193US6696437B1Heterocyclically substituted benzimidazoles, the production and application thereofABBOTT GMBH & CO KG·Filed 2000·Granted Feb 24, 2004·92 cites·22 claims
- 0289US7087637B2Substituted indoles which are PARP inhibitorsBASF AG·Filed 2001·Granted Aug 8, 2006·45 cites·21 claims
- 0387US6919342B2Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorABBOTT GMBH & CO KG·Filed 2004·Granted Jul 19, 2005·17 cites·15 claims
- 0486US6737421B1Cyclo-alkyl substituted benzimidazoles and their use as PARP inhibitorsABBOTT GMBH & CO KG·Filed 2000·Granted May 18, 2004·37 cites·23 claims
- 0584US6448271B1Substituted benzimidazoles and their use as parp inhibitorsBASF AG·Filed 1999·Granted Sep 10, 2002·59 cites·20 claims
- 0683US7041675B2Heterocyclic compounds and their use as PARP inhibitorsABBOTT GMBH & CO KG·Filed 2001·Granted May 9, 2006·22 cites·6 claims
- 0776US7851463B2Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorABBOTT GMBH & CO KG·Filed 2005·Granted Dec 14, 2010·2 cites·21 claims
- 0876US7320979B2N-[(piperazinyl)hetaryl]arylsulfonamide compoundsABBOTT GMBH & CO KG·Filed 2004·Granted Jan 22, 2008·7 cites·22 claims
- 0973US8969552B2Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorDRESCHER KARLA·Filed 2005·Granted Mar 3, 2015·2 cites·25 claims
- 1072USRE39608ESubstituted benzimidazoles and their use as PARP inhibitorsABBOTT GMBH & CO KG·Filed 1999·Granted May 1, 2007·30 cites·40 claims
- 1171US8232426B2Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorDRESCHER KARLA·Filed 2005·Granted Jul 31, 2012·1 cites·19 claims
- 1255US2007054918A1N-[(piperazinyl)hetary]arylsulfonamide compounds with affinity for the dopamine d3 receptorBRAJE WILFRIED·Filed 2004·Application pending·0 cites
- 1353US2004204422A1N-[(Piperazinyl)hetaryl]arylsulfonamide compoundsABBOTT GMBH & CO KG·Filed 2003·Application pending·0 cites
- 1452US8476275B2N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptorBRAJE WILFRIED·Filed 2011·Granted Jul 2, 2013·0 cites·3 claims
- 1548US8207160B2Tetrahydrobenzazepines and their use in he modulation of the dopamine D3 receptorBRAJE WILFRIED·Filed 2004·Granted Jun 26, 2012·0 cites·15 claims
- 1647US8383641B2Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorABBOTT GMBH & CO KG·Filed 2007·Granted Feb 26, 2013·0 cites·28 claims
- 1746US2005137186A1Tetrahydrobenzazepines and their useABBOTT GMBH & CO KG·Filed 2003·Application pending·0 cites
- 1846US2012220635A1Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptorDRESCHER KARLA·Filed 2012·Application pending·0 cites
- 1945US7834048B2Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorABBOTT GMBH & CO KG·Filed 2005·Granted Nov 16, 2010·0 cites·19 claims
- 2044US8470810B2Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorDRESCHER KARLA·Filed 2010·Granted Jun 25, 2013·0 cites·20 claims
- 2144US7759397B26-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorABBOTT GMBH & CO KG·Filed 2005·Granted Jul 20, 2010·0 cites·18 claims
- 2243US7994160B2Pyridazine compounds as glycogen synthase kinase 3 inhibitorsABBOTT GMBH & CO KG·Filed 2006·Granted Aug 9, 2011·0 cites·16 claims
- 2342US8497273B2Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptorGRANDEL ROLAND·Filed 2007·Granted Jul 30, 2013·0 cites·11 claims
- 2442US8486984B2Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorDRESCHER KARLA·Filed 2005·Granted Jul 16, 2013·0 cites·26 claims
- 2541US8202868B24-piperazinyl-pyrimidine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorHAUPT ANDREAS·Filed 2005·Granted Jun 19, 2012·0 cites·27 claims
- 2641US7026311B2Dibenzodiazepine derivatives, their preparation and useABBOTT GMBH & CO KG·Filed 2002·Granted Apr 11, 2006·0 cites·11 claims
- 2739US8642642B2Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptorGRANDEL ROLAND·Filed 2007·Granted Feb 4, 2014·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →